Myelofibrosis, JAK2 inhibitors and erythropoiesis

Leukemia. 2013 Jun;27(6):1219-23. doi: 10.1038/leu.2013.72.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Benzamides / therapeutic use*
  • Female
  • Humans
  • Janus Kinase 1 / antagonists & inhibitors*
  • Janus Kinase 2 / antagonists & inhibitors*
  • Male
  • Primary Myelofibrosis / drug therapy*
  • Pyrimidines / therapeutic use*

Substances

  • Benzamides
  • Pyrimidines
  • N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
  • Janus Kinase 1
  • Janus Kinase 2